A new study in the peer-reviewed Journal of Child and Adolescent Psychopharmacology estimated the incidence of neuroleptic malignant syndrome (NMS), a potentially fatal adverse effect of antipsychotic treatment, among individuals ages 5-24 years.
AstraZeneca to build $1.5bn ADC production facility in Singapore
The ADC manufacturing facility in Singapore is set to enhance global cancer treatment supply. Credit: Volodymyr Horbovyy / Shutterstock.com. AstraZeneca is set to invest $1.5bn